Catalyst Wire Dossier Catalyst Wire Dossier

Recombivax HB

Hepatitis B vaccine · Merck Sharp & Dohme LLC
Drug timelines are a Plus or Pro feature.

2 regulatory and trial events tracked for Recombivax HB, covering 2009-04-14 to 2017-03-16. Get the full timeline:

Most recent: Clinical Trial Update: A Research Study to Test Safety, Tolerability, and Immunogenicity of a Recombinant Hepatitis B Vaccine Manufactured With an Upgrade to the Production Process (V232-054) [Phase 3]

See pricing